| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.004 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.005 |